ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

RNLX Renalytix PLC

0.4418
-0.0739 (-14.33%)
22 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Renalytix PLC RNLX 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0739 -14.33% 0.4418 08:29:45
개장가 저가 고가 종가 전일 종가
0.5189 0.4351 0.5189 0.4356 0.5157
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/05/202423:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/05/202422:23EDGAR2Form 8-K - Current report
15/05/202420:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/05/202420:00EDGAR2Form 8-K - Current report
15/05/202420:00GLOBERenalytix Reports Financial Results for Third Quarter of..
09/05/202420:00GLOBERenalytix to Report Financial Results for Third Quarter..
08/04/202420:00GLOBERenalytix Announces Financing with Expected Size of up to $4..
14/03/202420:00GLOBEKidneyIntelX™ included in Final KDIGO 2024 Clinical..
15/02/202421:00GLOBERenalytix Reports Financial Results for Second Quarter of..
15/02/202421:00EDGAR2Form 8-K - Current report
15/02/202406:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/02/202423:00GLOBERenalytix to Participate in the BTIG MedTech, Digital..
17/01/202421:15EDGAR2Form 8-K - Current report
10/01/202421:15EDGAR2Form 8-K - Current report
10/01/202421:00GLOBENew published data demonstrates KidneyIntelX™ has broad..
30/12/202306:02EDGAR2Form 8-K - Current report
18/11/202306:01EDGAR2Form ARS - Annual Report to Security Holders
14/11/202321:00GLOBERenalytix Reports Financial Results for First Quarter of..
07/11/202321:00GLOBERenalytix to Report Financial Results for First Quarter..
04/11/202305:04EDGAR2Form PRE 14A - Other preliminary proxy statements
24/10/202321:00EDGAR2Form 8-K - Current report
06/10/202320:00GLOBEUS Patent Office Allows Patent Claims for Intellectual..
28/09/202320:00GLOBERenalytix Reports Full Year Fiscal 2023 Results
25/09/202320:00GLOBERenalytix to Report Financial Results for Fourth Quarter and..
09/09/202305:04EDGAR2Form 8-K - Current report
07/09/202320:00GLOBERenalytix Appoints Senior Executive Howard Doran as Chief..
03/08/202320:00GLOBERenalytix Clinical Advisory Board Formed to Support..
21/07/202320:00GLOBERenalytix Announces Middle East Distribution Agreement with..
07/07/202320:00GLOBELate-Breaking KidneyIntelX Evidence Released at 83rd..
03/07/202320:00GLOBERenalytix Appoints Financial Executive Catherine Coste to..
30/06/202307:58DJNRenalytix Gets FDA De Novo Marketing Authorization for..
30/06/202307:01GLOBEFDA Grants De Novo Marketing Authorization for..
15/06/202320:00GLOBEKidneyIntelX™ Clinical Decision Impact / Validation and..
09/06/202320:00GLOBERenalytix Reports Financial Results for Third Quarter of..
05/06/202320:00GLOBERenalytix to Report Third Quarter Fiscal Year 2023 Financial..
25/05/202320:00GLOBERenalytix selects EVERSANA® to expand commercialization of..